Every item below reads a draft stockholder ratifying consent against DGCL § 204(c)–(d). This is the stockholder-side half of a § 204 cure: where the defective corporate act being ratified would itself have required a stockholder vote — or resulted from a § 203 failure — the board's ratification must be submitted to stockholders, ordinarily by written consent under § 228 for a closely held company. The document is deliberately narrow; the substantive recitals (which acts, which dates, which failure of authorization) live in the Board Ratifying Consent this document approves. But two of its rules are easy to get wrong and each independently sinks the cure: the voting denominator is current law, not the original cap table, and the very putative shares being cured do not vote on their own ratification. For the background and the sequencing of the two consents, see the Delaware corporate-governance records practice guide. Whether stockholder approval is required at all for a given act remains a judgment for counsel.
0 of 2 checked
Approving the board's ratification
Confirm the consent approves the ratification of the specifically identified defective act(s) the board already approved, referencing or attaching the board's § 204(b) ratifying resolutions. DGCL § 204(c) frames the stockholder approval as an approval of a defined act to be submitted under subsection (d) , and § 204(d)(3) requires the accompanying notice to carry those resolutions — so the stockholder consent must approve the same named acts, not a free-standing sweep. “Each defective corporate act ratified pursuant to paragraph (b)(1) of this section shall be submitted to stockholders for approval as provided in subsection (d) of this section”
Confirm the approval is computed under the quorum and voting requirements applicable to the type of act at the time of the ratification — subject to any larger threshold the charter, bylaws, or a plan or agreement required as of the defective act — not the historic cap table. DGCL § 204(d)(4) fixes the denominator to current law ; taken by written consent, the consent must be signed by holders of at least the minimum votes needed to approve the ratification at a meeting . “the quorum and voting requirements applicable to the type of defective corporate act proposed to be ratified at the time of the approval of the ratification”
Sources for this section
Primary law
A.1 8 Del. C. § 204(c)A ratified defective act must be submitted to stockholders for approval under subsection (d) where the act would have required a stockholder vote — so the stockholder consent approves a defined, board-identified act.
Each defective corporate act ratified pursuant to paragraph (b)(1) of this section shall be submitted to stockholders for approval as provided in subsection (d) of this section
See 8 Del. C. § 204(c).
Primary law
A.2 8 Del. C. § 204(d)(4)The stockholder quorum and voting requirements are those applicable to the type of act at the time of the approval of the ratification — the current-law denominator, subject to any larger historic threshold.
the quorum and voting requirements applicable to the type of defective corporate act proposed to be ratified at the time of the approval of the ratification
See 8 Del. C. § 204(d)(4).
Primary law
A.3 8 Del. C. § 228(a)Stockholders may act by written consent signed by holders of at least the minimum number of votes needed to authorize the action at a meeting — the mechanism for a closely held company's ratifying consent.
may be taken without a meeting, without prior notice and without a vote, if a consent or consents, setting forth the action so taken, shall be signed by the holders of outstanding stock having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted
See 8 Del. C. § 228(a).
0 of 1 checked
The putative-stock voting trap
Confirm the approving percentage is computed without the putative shares being cured. DGCL § 204(d)(5) provides that putative stock as of the board's adoption of the ratifying resolutions is neither entitled to vote nor counted for quorum on the ratification — the shares whose validity is in question cannot supply the approval that would validate them. Counting them is the single most common error in a § 204 stockholder consent and produces an invalid approval. “shall neither be entitled to vote nor counted for quorum purposes in any vote to ratify any defective corporate act.”
Sources for this section
Primary law
B.1 8 Del. C. § 204(d)(5)Putative stock as of the board's adoption of the ratifying resolutions is neither entitled to vote nor counted for quorum in the vote to ratify — the shares being cured cannot vote on their own cure.
shall neither be entitled to vote nor counted for quorum purposes in any vote to ratify any defective corporate act.
See 8 Del. C. § 204(d)(5).